BioSig Lands Licensing Deal with Mayo Clinic

BioSig Technologies and Mayo Clinic have joined forces once again, this time to develop a new product pipeline to support some of the more advanced features of BioSig's Pure EP System. Samuel Asirvatham, MD, Mayo Clinic's vice-chair of innovation and medical director of the electrophysiology (EP) laboratory, will lead the new development program. The company previously signed a 10-year collaboration agreement with Mayo Clinic in March 2017. "The new product that we intend to develop under the latest licensing will seek to significantly advance the current arrhythmia treatments," said Kenneth Londoner, BioSig's CEO and chairman. "It will be an exciting journey, and we look forward to reporting on our progress.” BioSig's Pure EP System is intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing EP procedures. BioSig says its ultimate goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias such as atrial fibrillation and ventricular tachycardia.
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news

Related Links:

CONCLUSION: Findings from the review suggest that long-term, continuous, uninterrupted monitoring with Zio results in longer patient wear times and higher cardiac arrhythmia detection rates compared with outcomes reported in previous reviews of short-duration (24-48 hours) cardiac rhythm recording studies. PMID: 31045463 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Maximilian Funken1,2, Daniela Malan1, Philipp Sasse1* and Tobias Bruegmann1,3,4,5* 1Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany 2Department of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany 3Research Training Group 1873, University of Bonn, Bonn, Germany 4Institute of Cardiovascular Physiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany 5DZHK (German Research Centre for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany Cardiac defibrillation to terminate lethal vent...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
Conclusions: Embolism associated with asymptomatic carotid stenosis shows circadian variation with highest rates 4–6 h before midday. This corresponds with peak circadian incidence of stroke and other vascular complications. These and ASED Study results show that monitoring frequency, duration, and time of day are important in ES detection. Introduction Transcranial Doppler (TCD) detected microembolism in the ipsilateral middle cerebral artery (MCA) may help stratify the risk of stroke and other arterial disease complications in persons with advanced (≥60%) asymptomatic carotid stenosis. If so, this techniqu...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
CONCLUSIONS: discordant shock advisements were observed for each AED and varied between manufacturers, most often involving VF. There may be implications for termination of resuscitation decision making. BACKGROUND: PMID: 30892980 [PubMed - as supplied by publisher]
Source: Prehospital Emergency Care - Category: Endocrinology Tags: Prehosp Emerg Care Source Type: research
Publication date: Available online 15 December 2018Source: Canadian Journal of CardiologyAuthor(s): Judith Brouillette, Samuel Cyr, Céline FisetAbstractLong-term survival of Human Immunodeficiency Virus (HIV) infected patients has significantly improved with the use of antiretroviral therapy (ART). As a consequence, cardiovascular diseases are now emerging as an important clinical problem in this population. Sudden cardiac death is the third leading cause of mortality in HIV patients. Twenty percent of HIV patients who died from sudden cardiac death had prior cardiac arrhythmias, including ventricular tachycardia, a...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Conclusion: The cardiac arrhythmogenicity of various opioids is different. Methadone has a higher capability to induce long QT interval and dangerous arrhythmias in conventional doses than others. To reduce of arrhythmogenic risk, high doses of opioids must be used cautiously with periodic monitoring of electrocardiogram in high-risk consumers such as patients under opioid maintenance treatment.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
H. Chon We developed an automated approach to differentiate between different types of arrhythmic episodes in electrocardiogram (ECG) signals, because, in real-life scenarios, a software application does not know in advance the type of arrhythmia a patient experiences. Our approach has four main stages: (1) Classification of ventricular fibrillation (VF) versus non-VF segments—including atrial fibrillation (AF), ventricular tachycardia (VT), normal sinus rhythm (NSR), and sinus arrhythmias, such as bigeminy, trigeminy, quadrigeminy, couplet, triplet—using four image-based phase plot features, one fr...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
Prognostic Value of Electrocardiography in Patients With Fulminant Myocarditis Supported by Percutaneous Venoarterial Extracorporeal Membrane Oxygenation - Analysis From the CHANGE PUMP Study. Circ J. 2018 Jun 01;: Authors: Sawamura A, Okumura T, Ito M, Ozaki Y, Ohte N, Amano T, Murohara T, CHANGE PUMP Investigators Abstract BACKGROUND: Fulminant myocarditis (FM) presents various abnormal findings on ECG, the prognostic impact of which has not been not fully elucidated. The aim of this study was therefore to clarify the prognostic value of ECG data in FM patients supported by venoarterial extracorpo...
Source: Circulation Journal - Category: Cardiology Authors: Tags: Circ J Source Type: research
ConclusionsAn ILR has excellent diagnostic yield for syncope, palpitations, and suspected AF, and a considerable proportion of patients undergo ILR-directed interventions following monitoring. ILR implantation is a low-risk procedure.
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research
ConclusionLMNA mutation prevalence was 6.2% of familial DCM in Norway. Cardiac penetrance was high in young asymptomatic LMNA genotype-positive family members with frequent AV block and VT, highlighting the importance of early family screening and cardiological follow-up. Nearly 20% of the LMNA patients required heart transplantation.
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Electrocardiogram | Laboratory Medicine | Medical Devices | Ventricular Tachycardia